Strong Stocks - As of January 20, the Shanghai Composite Index fell by 0.01% to 4113.65 points, the Shenzhen Component Index decreased by 0.97% to 14155.63 points, and the ChiNext Index dropped by 1.79% to 3277.98 points. A total of 62 stocks in the A-share market hit the daily limit up [1] - The top three strong stocks based on current consecutive limit-up counts and daily trading data are: Xinyuan Electronics (002546), Jiuding New Materials (002201), and Zhaojin Gold (000506) [1] - Detailed data for the top 10 strong stocks includes: - Xinyuan Electronics (002546): 4 days, 3 limit-ups, turnover rate of 27.31% - Jiuding New Materials (002201): 5 days, 3 limit-ups, turnover rate of 32.1% - Zhaojin Gold (000506): 2 consecutive limit-ups, turnover rate of 10.64% [1] Concept Performance - The epoxy propylene concept saw a rise of 5.78%, with 20.83% of its component stocks hitting the limit up and 87.5% of its component stocks rising [2] - The glyphosate concept increased by 3.45%, with 5.88% of its component stocks hitting the limit up and 82.35% of its component stocks rising [2] - The acrylic acid concept rose by 2.64%, with 5.56% of its component stocks hitting the limit up and 72.22% of its component stocks rising [2] - The NMN concept increased by 1.95%, with 4.0% of its component stocks hitting the limit up and 64.0% of its component stocks rising [2] - The cultivated diamond concept rose by 1.93%, with 5.56% of its component stocks hitting the limit up and 66.67% of its component stocks rising [2] - The rental and sales rights concept increased by 1.75%, with 10.71% of its component stocks hitting the limit up and 64.29% of its component stocks rising [2] - The cement concept rose by 1.59%, with 2.27% of its component stocks hitting the limit up and 77.27% of its component stocks rising [2] - The beer concept increased by 1.52%, with 10.0% of its component stocks hitting the limit up and 60.0% of its component stocks rising [2] - The Guangdong Free Trade Zone concept rose by 1.44%, with 11.11% of its component stocks hitting the limit up and 66.67% of its component stocks rising [2] - The high dividend selection concept increased by 1.39%, with 0.0% of its component stocks hitting the limit up and 80.0% of its component stocks rising [2]

Group 1 - The epoxy propylene concept increased by 5.78%, ranking first among concept sectors, with 21 stocks rising, including Meibang Technology with a 30% limit up, and China Chemical, Hongqiang Co., and Weiyuan Co. also hitting the limit up [1][2] - The leading gainers in the epoxy propylene sector included Yida Co. with an 11.96% increase, Huitong Technology with a 7.84% rise, and Yinuowei with a 7.64% increase [1][2] - The stocks with the largest declines included Shida Shenghua, Guoen Co., and Yonghe Co., which fell by 3.52%, 2.04%, and 0.39% respectively [1] Group 2 - The epoxy propylene sector saw a net inflow of 1.05 billion yuan, with 15 stocks receiving net inflows, and 6 stocks attracting over 50 million yuan in net inflows [2] - The top stock for net inflow was Hongbaoli, with a net inflow of 338 million yuan, followed by China Chemical with 262 million yuan, and Wanhua Chemical with 174 million yuan [2] - The net inflow ratios for leading stocks were Hongbaoli at 46.60%, Hongqiang Co. at 42.22%, and Weiyuan Co. at 17.98% [3]

Group 1 - The NMN concept index rose by 1.95%, ranking fourth among concept sectors, with 16 stocks increasing in value, including Meibang Technology which hit a 30% limit up [1] - Notable gainers in the NMN sector included Hongyang Sun, Youa Shares, and Chenguang Biology, which rose by 6.54%, 3.52%, and 3.35% respectively [1] - The sector experienced a net outflow of 51 million yuan in main funds, with six stocks seeing net inflows, led by Zhongsheng Pharmaceutical with a net inflow of 93.86 million yuan [2][3] Group 2 - The main fund inflow ratios were highest for Guoyao Modern, Zhongsheng Pharmaceutical, and Hongyang Sun, with net inflow rates of 6.13%, 4.99%, and 3.77% respectively [3] - The NMN concept fund inflow rankings showed Zhongsheng Pharmaceutical at 1.80% increase with a turnover rate of 11.13%, while Hongyang Sun had a 6.54% increase with a turnover rate of 9.10% [3][4] - Stocks like Yaba Chemical and Anqi Yeast showed negative fund flow, indicating potential concerns in their performance, with Yaba Chemical at -317.96 million yuan and Anqi Yeast at -610.36 million yuan [4]

Core Viewpoint - The stock of Jinggong Steel Structure has shown a mixed performance in recent trading, with a year-to-date increase of 8.67% but a slight decline of 1.96% over the past five trading days [1] Group 1: Stock Performance - As of January 19, Jinggong Steel Structure's stock price was 4.51 CNY per share, with a market capitalization of 8.975 billion CNY [1] - The stock has experienced a trading volume of 85.8353 million CNY, with a turnover rate of 0.96% [1] - The stock has increased by 5.37% over the past 20 days and by 10.00% over the past 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Jinggong Steel Structure reported a revenue of 14.557 billion CNY, reflecting a year-on-year growth of 20.85% [2] - The net profit attributable to shareholders for the same period was 590 million CNY, representing a year-on-year increase of 24.02% [2] Group 3: Shareholder Information - As of November 10, the number of shareholders for Jinggong Steel Structure was 78,400, with an average of 25,398 circulating shares per shareholder [2] - The company has distributed a total of 799 million CNY in dividends since its A-share listing, with 350 million CNY distributed in the last three years [3] - Notable changes in institutional holdings include Hong Kong Central Clearing Limited becoming the third-largest shareholder, increasing its holdings by 39.035 million shares [3]

Core Viewpoint - The stock of Te Yi Pharmaceutical experienced a decline of 2.15% on December 23, with a current price of 10.93 CNY per share and a market capitalization of 5.607 billion CNY. The company has shown a year-to-date stock price increase of 22.80% but has faced recent declines in the short term [1]. Financial Performance - For the period from January to September 2025, Te Yi Pharmaceutical achieved a revenue of 692 million CNY, representing a year-on-year growth of 51.86%. The net profit attributable to shareholders was 65.217 million CNY, showing a significant increase of 985.18% compared to the previous year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for Te Yi Pharmaceutical was 58,100, an increase of 10.11% from the previous period. The average number of tradable shares per shareholder decreased by 9.09% to 6,481 shares [2]. Dividend Distribution - Te Yi Pharmaceutical has distributed a total of 1.059 billion CNY in dividends since its A-share listing, with 356 million CNY distributed over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, the third-largest shareholder is the Xingquan Zhongzheng 800 Six-Month Holding Index Enhanced A, holding 3.3338 million shares. The fourth-largest is the Xingquan Hu-Shen 300 Index Enhanced (LOF) A, holding 1.9202 million shares, both of which have not changed in quantity compared to the previous period. The Hong Kong Central Clearing Limited, ranked ninth, reduced its holdings by 7.4217 million shares to 1.3696 million shares [3].

Core Viewpoint - Brother Technology's stock has shown significant performance this year, with a year-to-date increase of 49.65%, despite recent fluctuations in the short term [1][2]. Financial Performance - For the period from January to September 2025, Brother Technology achieved a revenue of 2.725 billion yuan, representing a year-on-year growth of 4.84%. The net profit attributable to the parent company was 101 million yuan, marking a substantial increase of 211.75% [2]. Stock Market Activity - As of December 19, Brother Technology's stock price was 6.36 yuan per share, with a market capitalization of 7.268 billion yuan. The stock experienced a trading volume of 60.6529 million yuan and a turnover rate of 1.37% [1]. - The company has appeared on the "Dragon and Tiger List" nine times this year, with the most recent appearance on September 25, where it recorded a net buy of -58.0197 million yuan [1]. Shareholder Information - As of September 30, 2025, Brother Technology had 101,600 shareholders, an increase of 61.51% from the previous period. The average number of circulating shares per shareholder was 6,906, which decreased by 38.08% [2]. - The top ten circulating shareholders include significant institutional investors, with notable increases in holdings from certain ETFs [3]. Business Overview - Brother Technology, established on March 19, 2001, and listed on March 10, 2011, operates in the fields of vitamins, leather chemicals, flavoring agents, raw materials for pharmaceuticals, and catalytic new materials. The main revenue sources are pharmaceuticals and food (58.88%), specialty chemicals (38.21%), and others (2.91%) [1].

Group 1 - The core viewpoint of the news is that Yinxin Technology's stock has experienced fluctuations, with a current price of 9.23 CNY per share and a market capitalization of 4.373 billion CNY, while the company has shown significant revenue and profit growth year-to-date [1][2]. Group 2 - As of September 30, Yinxin Technology had 34,600 shareholders, an increase of 1.87% from the previous period, with an average of 13,204 circulating shares per shareholder, a decrease of 0.97% [2]. - For the period from January to September 2025, Yinxin Technology achieved operating revenue of 1.653 billion CNY, representing a year-on-year growth of 16.75%, and a net profit attributable to shareholders of 84.714 million CNY, which is an increase of 116.39% year-on-year [2]. Group 3 - Since its A-share listing, Yinxin Technology has distributed a total of 177 million CNY in dividends, with no dividends paid in the last three years [3].

Core Viewpoint - The stock price of Te Yi Pharmaceutical has shown significant growth this year, with a year-to-date increase of 56.84% and a recent surge of 14.52% over the last five trading days [2] Group 1: Stock Performance - As of November 27, Te Yi Pharmaceutical's stock price rose by 2.57% to 13.96 CNY per share, with a trading volume of 8.83 billion CNY and a turnover rate of 17.18%, resulting in a total market capitalization of 71.62 billion CNY [1] - The company has appeared on the stock market's "Dragon and Tiger List" 12 times this year, with the most recent appearance on November 26, where it recorded a net buy of -19.39 million CNY [2] Group 2: Financial Performance - For the period from January to September 2025, Te Yi Pharmaceutical achieved a revenue of 6.92 billion CNY, reflecting a year-on-year growth of 51.86%, while the net profit attributable to shareholders reached 65.22 million CNY, marking an impressive increase of 985.18% [2] - The company has distributed a total of 10.59 billion CNY in dividends since its A-share listing, with 3.56 billion CNY distributed over the past three years [3] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Te Yi Pharmaceutical increased to 58,100, a rise of 10.11%, while the average circulating shares per person decreased by 9.09% to 6,481 shares [2] - Among the top ten circulating shareholders, the third-largest is the Xingquan Zhongzheng 800 Six-Month Holding Index Enhanced A, holding 3.33 million shares, while the fourth is the Xingquan Hu-Shen 300 Index Enhanced A, holding 1.92 million shares, both unchanged from the previous period [3]

Core Viewpoint - Brother Technology's stock has shown significant volatility, with a year-to-date increase of 55.06% but a recent decline in the last five trading days by 5.72% [1] Financial Performance - For the period from January to September 2025, Brother Technology achieved a revenue of 2.725 billion yuan, representing a year-on-year growth of 4.84% [2] - The net profit attributable to the parent company for the same period was 101 million yuan, showing a substantial increase of 211.75% year-on-year [2] Stock Market Activity - As of November 25, Brother Technology's stock price was 6.59 yuan per share, with a market capitalization of 7.531 billion yuan [1] - The stock has been on the龙虎榜 (a list of stocks with significant trading activity) nine times this year, with the most recent appearance on September 25, where it recorded a net buy of -58.0197 million yuan [1] Shareholder Information - As of September 30, 2025, the number of shareholders for Brother Technology increased to 101,600, a rise of 61.51% from the previous period [2] - The average number of circulating shares per shareholder decreased by 38.08% to 6,906 shares [2] Dividends and Institutional Holdings - Since its A-share listing, Brother Technology has distributed a total of 390 million yuan in dividends, with 106 million yuan distributed over the last three years [3] - Among the top ten circulating shareholders, the Guotai Zhongzheng Livestock Breeding ETF holds 14.1311 million shares, an increase of 5.0455 million shares from the previous period [3]

Core Viewpoint - The stock of Kingdawei has experienced a decline recently, with a notable drop in trading volume and fluctuations in shareholder numbers, despite a year-to-date increase in stock price and significant growth in revenue and net profit [1][2]. Financial Performance - For the period from January to September 2025, Kingdawei achieved a revenue of 2.604 billion yuan, representing a year-on-year growth of 11.16% [2]. - The net profit attributable to shareholders for the same period was 361 million yuan, showing a substantial increase of 63.47% compared to the previous year [2]. Stock Market Activity - As of November 21, Kingdawei's stock price was 18.96 yuan per share, with a market capitalization of 11.564 billion yuan [1]. - The stock has increased by 28.98% year-to-date, but has seen a decline of 9.11% over the last five trading days [1]. Shareholder Information - As of September 30, the number of shareholders for Kingdawei was 36,300, a decrease of 10.95% from the previous period [2]. - The average number of circulating shares per shareholder increased by 12.29% to 16,817 shares [2]. Dividend Distribution - Kingdawei has distributed a total of 2.761 billion yuan in dividends since its A-share listing, with 488 million yuan distributed over the last three years [3]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder, holding 7.7408 million shares, an increase of 803,600 shares from the previous period [3]. - The Southern CSI 1000 ETF and Huaxia CSI 1000 ETF were among the top ten circulating shareholders, with slight changes in their holdings [3].